The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 31, 2013

Filed:

Jul. 15, 2008
Applicants:

Thavalakulamgara K. Sasikumar, Edison, NJ (US);

Duane A. Burnett, Bernardsville, NJ (US);

Theodros Asberom, West Orange, NJ (US);

Wen-lian Wu, Edison, NJ (US);

Hongmei LI, Warren, NJ (US);

Ruo Xu, Watchung, NJ (US);

Hubert B. Josien, Jersey City, NJ (US);

Inventors:

Thavalakulamgara K. Sasikumar, Edison, NJ (US);

Duane A. Burnett, Bernardsville, NJ (US);

Theodros Asberom, West Orange, NJ (US);

Wen-Lian Wu, Edison, NJ (US);

Hongmei Li, Warren, NJ (US);

Ruo Xu, Watchung, NJ (US);

Hubert B. Josien, Jersey City, NJ (US);

Assignee:

Merck Sharp & Dohme Corp., Rahway, NJ (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A01N 43/42 (2006.01); A01N 43/18 (2006.01); A01N 43/16 (2006.01); A01N 41/10 (2006.01); A61K 31/44 (2006.01); A61K 31/38 (2006.01); A61K 31/35 (2006.01); A61K 31/10 (2006.01); C07D 221/18 (2006.01); C07D 221/22 (2006.01); C07D 409/00 (2006.01); C07D 335/04 (2006.01); C07D 495/00 (2006.01); C07D 311/78 (2006.01); C07D 311/94 (2006.01); C07C 315/00 (2006.01); C07C 317/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

Disclosed are novel gamma secretase inhibitors of the formula (I): or a pharmaceutically acceptable salt, solvate, or ester thereof, wherein L, n, X, Ar, Y, Z, Q, and Qare as defined herein. Also disclosed are methods for inhibiting gamma secretase, methods for treating Alzheimer's disease, methods of treating one or more neurodegenerative diseases, and methods of inhibiting the deposition of amyloid protein (e.g., amyloid beta protein) in, on or around neurological tissue (e.g., the brain) using the compounds of formula 1.0.


Find Patent Forward Citations

Loading…